Division of Neonatology, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Center for Intestinal and Liver Inflammation Research, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, IL 60611, USA.
Nutrients. 2021 Oct 23;13(11):3751. doi: 10.3390/nu13113751.
Growing evidence demonstrates human milk's protective effect against necrotizing enterocolitis (NEC). Human milk derives these properties from biologically active compounds that influence intestinal growth, barrier function, microvascular development, and immunological maturation. Among these protective compounds are growth factors that are secreted into milk with relatively high concentrations during the early postnatal period, when newborns are most susceptible to NEC. This paper reviews the current knowledge on human milk growth factors and their mechanisms of action relevant to NEC prevention. It will also discuss the stability of these growth factors with human milk pasteurization and their potential for use as supplements to infant formulas with the goal of preventing NEC.
越来越多的证据表明,人乳对坏死性小肠结肠炎(NEC)具有保护作用。人乳通过具有生物活性的化合物获得这些特性,这些化合物影响肠道生长、屏障功能、微血管发育和免疫成熟。在这些保护性化合物中,有生长因子,它们在新生儿最易患 NEC 的出生后早期,以相对较高的浓度分泌到乳汁中。本文综述了人乳生长因子及其与 NEC 预防相关的作用机制的最新知识。还将讨论这些生长因子在人乳巴氏消毒过程中的稳定性及其作为婴儿配方奶粉补充剂的潜在用途,以预防 NEC。